Navigation Links
Poniard Pharmaceuticals Announces Plan for Voluntary Prepayment of Term Loan and Transfer to Nasdaq Capital Market
Date:12/16/2010

SOUTH SAN FRANCISCO, Calif., Dec. 16, 2010 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced that it has provided notice of voluntary prepayment of its senior secured loan facility to GE Business Financial Services Inc. and Silicon Valley Bank.  The Company expects to pay the approximately $12.3 million balance on the facility, including interest and other fees payable under the loan agreement, prior to year-end.  Once repaid, all covenants and restrictions related to the facility will lift, including lender consent requirements restricting certain asset sales, mergers and acquisition transactions and financial covenants requiring the Company to maintain a minimum amount of unrestricted cash.

The Company also announced today that it received approval from the Nasdaq Stock Market Listing Qualifications Staff to transfer the listing of its common stock from The Nasdaq Global Market to The Nasdaq Capital Market.  This transfer will be effective at the opening of business on Friday, December 17, 2010, and the Company's common stock will continue to trade under the symbol "PARD."  The Nasdaq Capital Market is a continuous trading market that operates in substantially the same manner as The Nasdaq Global Market.  All companies listed on The Nasdaq Capital Market must meet certain financial requirements and comply with Nasdaq's corporate governance requirements.

"The steps taken today serve to free up capital and assets as well as maintain the continued liquidity of our common stock and Nasdaq listing status as we continue our ongoing review of strategic alternatives aimed at optimizing the value of the Company and of our lead program, picoplatin," said Ronald A. Martell, chief executive officer of Poniard Pharmaceuticals.  "We continue t
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals Reports Third Quarter 2010 Financial Results
2. Poniard Pharmaceuticals Awarded $244,479 Grant Under Qualifying Therapeutic Discovery Project Program
3. Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price
4. Poniard Announces Final Data from Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer
5. Poniard Pharmaceuticals Announces $6.3 Million Financing
6. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
7. Poniard Pharmaceuticals to Present at 12th Annual BIO CEO and Investor Conference
8. Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
9. Poniard Pharmaceuticals Announces Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives
10. Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results
11. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 25, 2015 Research ... announced the addition of the "2015 Strategies ... to their offering. This comprehensive five-country ... designed to help current suppliers and potential market ... the European coagulation testing market during the next ...
(Date:5/27/2015)... CITY , May 27, 2015  Vital Access ... $10 million credit facility with Deerfield Management, a healthcare ... to fund Vital Access, continued global expansion of its ... investment in the Company,s proprietary vascular access platform. ... as a financial partner. Deerfield is a healthcare investor ...
(Date:5/27/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/d85hx9/global_rapid ) has ... Diagnostic Kits Market - Applications and Technologies" report ... Medical Diagnostic Kits, estimated at US$19.4 billion in 2014, ... to maintain a CAGR of 5.7% between 2014 and ... The global market for Rapid Medical Diagnostic ...
Breaking Medicine Technology:European Coagulation Testing Market Strategies 2015 2Vital Access Receives $10 Million Financing Commitment from Deerfield 2Vital Access Receives $10 Million Financing Commitment from Deerfield 3Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 2Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 3Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 4
(Date:5/27/2015)... New York (PRWEB) May 27, 2015 ... filed on behalf of individuals who allegedly ... related to the use of the antipsychotic drug ... litigation currently underway in Pennsylvania’s Philadelphia Court of ... is proceeding with its bellwether trial program, as ...
(Date:5/27/2015)... With the launch of the Centers ... Management Module (NMM) tool, monitoring provider-network adequacy will take ... Atlantic Information Services, Inc.’s (AIS) Medicare Advantage News (MAN) ... well as analysis from industry experts on why CMS ... to the NMM were announced at CMS’s recently held ...
(Date:5/27/2015)... In today's healthcare landscape, where costs ... be challenging for doctors and hospitals to keep up ... , Austin-based HealthTronics, Inc. is offering a ... therapies for clinically sophisticated applications. The company has now ... Laser Ventures, Inc ., a mobile laser technology ...
(Date:5/27/2015)... 27, 2015 Dr. Omar Ibrahimi, Dermatologist ... Stamford, CT has been selected as part of a ... nationwide (and the only physician in Connecticut) to offer ... for the removal of submental fat (double chin). The ... time, no surgery and minimal risks. Dr. Ibrahimi is ...
(Date:5/27/2015)... 27, 2015 NOVAtime Technology, Inc. ... Management solutions for enterprise organizations, announced today that ... to automate its time, attendance and point tracking ... in the United States. , Family-owned since ... of 21 retail, private label, and mill brands. ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 3Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 2Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 3Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3
... ... to educate people about ,bipolar disorder , , ... Wilmington, DE (PRWEB) November 11, 2009 -- As part of a panel ... firsthand by this disease. Debi was joined in New York by people living with ...
... Pa., Nov. 12 You,re visiting the dentist for what ... or she says you need a root canal. Though it,s ... one in the chair, you may have several questions and ... feared root canals for quite some time. The Pennsylvania Dental ...
... an industry faced with unprecedented uncertainty. One of the ... and clearly communicate relevant and timely messages to an ... & Krause (GY&K) reaffirmed its commitment to exceptional healthcare ... six national CardioVascular Advertising (CVA) Awards. , "Our ...
... GREENGUARD product certification pilot significantly expands chemical emissions ... harmful chemicals from products used in multiple environments. ... Environmental Institute (GEI) announces the launch of GREENGUARD ... existing stringent indoor air quality criteria, additional chemical ...
... Mesa Laboratories, Inc. (Nasdaq: MLAB ) today announced that ... of $.11 per share of common stock, up from $.10 ... December 15, 2009, to shareholders of record on November 30, ... maintained strong cash positions and has continued to build its ...
... WILMINGTON, Del., Nov. 12 Christiana Care ... first community hospital in the nation to submit specimens ... Genome Atlas (TCGA) Project. The project is part of ... to help doctors diagnose, treat and even prevent cancer ...
Cached Medicine News:Health News:Actress Debi Mazar Talks About her Family's Experience with Bipolar Depression 2Health News:Actress Debi Mazar Talks About her Family's Experience with Bipolar Depression 3Health News:Painful Root Canals Are a Thing of the Past 2Health News:Healthcare Organizations Face Tough Marketing Challenges - GY&K Asks 'Are You Relevant?' 2Health News:Healthcare Organizations Face Tough Marketing Challenges - GY&K Asks 'Are You Relevant?' 3Health News:GREENGUARD Launches Comprehensive Health-Based Certification Pilot Program 2Health News:Christiana Care First Community Hospital to Submit Samples to Cancer Genome Atlas Project 2
... The ImmunoWELL VCA IgM Test is an ELISA ... to Epstein-Barr Virus viral capsid antigen (VCA) in ... used in conjunction with other testing such as ... EBV early antigen tests and/or heterophile tests, the ...
... ImmunoDOT Borrelia (Lyme) test is ... test for the qualitative detection ... (anti-P39) and related Borrelia burgdorferi ... are detected in serum as ...
... Borrelia DotBlot M Tests are qualitative enzyme ... Borrelia burgdorferi antibodies (IgG or IgM, respectively) ... these tests should be supplemented with a ... can be used to support a clinical ...
... Borrelia DotBlot G Tests are qualitative enzyme ... Borrelia burgdorferi antibodies (IgG or IgM, respectively) ... these tests should be supplemented with a ... can be used to support a clinical ...
Medicine Products: